Introduction
The long QT syndrome (LQTS) is a genetic disease with a prevalence of 1 in 2000 live births 1 and is associated with a high risk for lifethreatening arrhythmias among untreated patients. 2, 3 However, with appropriate treatment, mortality has now been reduced to below 1%. 3 Sudden death is often the sentinel event, and cardiac events usually appear in childhood or adolescence. Long QT syndrome also contributes to almost 10% of cases of sudden infant death syndrome 4 and early identification of LQTS through electrocardiogram (ECG) screening performed in the first month of life is likely to reduce mortality. 5 The usefulness of neonatal ECG screening for the identification of LQTS has been demonstrated by two separate prospective studies involving almost 78 000 infants. 1, 6 Even though the number of clinical centres worldwide offering a service of neonatal electrocardiography is constantly growing, the question of which is the best method for the heart rate (HR) correction of the QT interval in neonates, given their high HRs remains unanswered. The method used in most studies in newborns 1, 6, [7] [8] [9] is the one derived from the article by Bazett 10 in 1920 (corrected QT or QTcB = QT/ ffiffiffiffiffiffi RR p Þ. However, the endless criticism that this formula overcorrects the QT interval at high HRs has led many investigators to propose alternative formulae. [11] [12] [13] Most of these publications suffer from several limitations: (i) many small cohorts, (ii) large cohorts but with automated measurements with various degrees of unreliability, and (iii) validation in children or adult populations but not in neonates. Moreover, no attempts were made to verify whether or not the other QT correction methods could reliably identify infants with an established diagnosis of LQTS which, after all, should be the main reason to measure their QT interval. This study was specifically designed to verify in a large population of infants which, among the many QT correction methods currently used or proposed, is superior and sufficiently reliable to identify those with LQTS.
Methods
This study was performed using ECGs recorded in healthy neonates, enrolled in a prospective study, which assessed and defined the prevalence of congenital LQTS. 1 
Study population
The original study 1 , and in whom an ECG was recorded between the 15th and the 25th day of life. All parents signed an informed consent for recording the ECG. Very premature and sick newborns who required transfer to neonatal intensive care units were excluded from the study.
The protocol requested genetic analysis in all infants with a QTc >470 ms and in their parents, and recommended it in those with a QT >460 ms. All coding exons of KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, CAV3, and SCN4B (the genes screened at that time in our laboratory for the routine diagnosis of LQTS) were analysed for presence of diseasecausing mutations. The details of the genetic analysis have been described. 1 There were 59 neonates with a QTc >460 ms and 43 of them (90% of those above 470 ms and 50% of those above 460 ms) underwent genetic analysis. For this study, we analysed 5000 ECGs, which included all 43 ECGs with QTc >460 ms of the infants who underwent genotyping, and another 4957 ECGs all recorded at a single centre to reduce variability (this centre enrolled 5007 infants but we randomly excluded 50 of them to end up with a cohort of 5000). All these tracings were part of the 44 553 ECGs from the original dataset. These 5000 neonates included 2562 (51.2%) males and 2438 (48.8%) females.
ECG recording and analysis
The ECGs were recorded at a paper speed of 25 mm/s with a Marquette MAC 5000 recorder (digital sampling rate 500 Hz) and were transmitted from the participating centre via modem to the study co-ordinating centre and were read centrally. The QT intervals and the preceding RR intervals were measured on-screen manually in leads II, V5, and V6 from five non-consecutive beats. During ECG analysis, the QTc was calculated according to Bazett's formula (QTcB) and the longest mean value of the five beats found in one of the three leads was considered. In neonates with a QTcB >450 ms, another ECG was recorded within 1 to 2 weeks to confirm the initial finding. ECGs were analysed as per the European Society of Cardiology guidelines for the interpretation of neonatal ECG and if QT prolongation or any other ECG abnormality was identified, the infants were managed and treated accordingly.
14 Bradycardia was defined as HR <107 b.p.m. and tachycardia as HR >182 b.p.m. 14 The QT and RR interval values from each ECG were used to calculate the corrected QT (QTc) interval using four commonly used HR correction formulae:
Statistical analysis
All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).
Differences in QTc and RR intervals between males and females were compared with the Student's t-test.
To identify which of the QT correction formulae was most appropriate for use in neonates, we plotted the QTc against HR values from each ECG and the slope with its 95% confidence interval (CI) of QTc-HR regression line was determined for each formula by linear mixed effects model using the PROC MIXED function in SAS. The QT correction formula with the slope of the regression line closest to zero was considered the best as it would provide a QTc value that was most independent of HR. Comparison of slopes between correction formulae was also performed by including the 'correction method Â concentration' interaction term in the linear mixed effects model and the mean difference with 95% CI was reported.
To determine if a neonate-specific QT correction (QTcNeo) formula was better than the other formulae studied, the dataset of 5000 ECGs was randomly split into two equal halves (a study dataset and a validation dataset of 2500 ECGs each), using a random number generator. For calculating the correction factor, the relationship between the HR and QT values in the study dataset was evaluated by the formula: Log QT = a þ b*Log RR. Having obtained the value of b, this was then used to calculate QTcNeo using the formula QTcNeo = QT/RR b . The performance of the QTcNeo formula was evaluated using the remaining 2500 ECGs by comparing the slope of its QTc-HR regression line with the slope of the QTc-HR regression line of the best of the four other QT correction formulae studied.
To assess the diagnostic performance of each correction method in identifying neonates with or without a LQTS disease-causing mutation, receiver operating characteristic (ROC) curves were generated. The area under the ROC (AuROC) was calculated with its 95% CI using the PROC LOGISTIC function in the SAS statistical software package. A v 2 test of significance was used to compare the areas under correlated ROC curves for different QTc methods, 18 and the one with the largest AuROC was considered the best correction method for this purpose. The Youden's J statistic was used to determine the cut-off values for each QT correction formula that best separated those with LQTS from those who did not. A two-sided P-value <0.05 was considered statistically significant.
Results
The mean (± standard deviation) HR for the 5000 ECGs was 154 ± 17 b.p.m. and mean QT interval was 252 ± 19 ms ( Table 1) . The QTc values by the four QT correction formulae (Bazett's, Fridericia's, Hodges', and Framingham) did not differ significantly between males and females ( Table 2) . Of the 2438 females, five had bradycardia and 99 had tachycardia. Similarly, 3 of the 2562 males had bradycardia and 122 had tachycardia.
Regression analysis of QTc and heart rate
Linear regression analysis of the QTc values vs. HR showed that the Hodges' formula (QTcH) grossly over-corrected for the effect of HR (Take home figure) . QTcL (Framingham) and QTcF (Fridericia) slight under-corrected for the effect of HR, and had more or less similar slopes. QTcB minimally overcorrected for the effect of HR on the QT interval but had a slope that was the closest to the horizontal ( Table 3 ), indicating that it provided a better HR independent estimate of QTc than the other three methods studied (Take home figure) .
Calculation of neonate-specific QT correction (QTcNeo)
The relationship between HR and QT values of the study dataset of 2500 neonates was evaluated by the formula: Log QT ¼ a þ b*Log RR. The slope (b) in this equation was 0.467. Based on this analysis, the population-specific QT correction formula for neonates was found to be QTcNeo = QT/RR 0.467
.
The performance of QTcNeo and QTcB were studied in the validation dataset by plotting QTc vs. HR. The R 
Ability to identify neonates with long QT syndrome
Of the 5000 neonates evaluated in this study, genetic analysis identified 17 who were carrying a LQTS-causing mutation (LQT1 = 9, LQT2 = 6, LQT5 = 1, and LQT6 = 1). Based on this identification of neonates with 'true positive' LQTS, sensitivity and specificity analyses were used to generate the ROC curves and the AuROC was calculated for each of the QT correction methodology and compared. The AuROC for QTcB, QTcF, QTcL, and QTcNeo were comparable ( Table 4 and Figure 2 ). The AuROC for QTcH was significantly lower than the AuROC for the other 4 QT correction methods ( Table 4) . Cut-off values that provided the best sensitivity and specificity for the correction methods were 383 ms for QTcL, 394 ms for QTcF, 446 ms for QTcNeo, and 460 ms for QTcB; all these four correction formulae had negative predictive values of 100% and positive predictive values in the range of 32-40% using the above mentioned cut-off values ( Table 5 ). The optimum cut-off value for QTcH was 434 ms and it had a specificity of only 80%; 978 of 5000 neonates had QTcH values above the cut-off and only 1.7% of these had LQTS ( Table 5) .
Discussion
The main finding of this study is that, with one exception, most QT interval correction formulae provide relatively similar results in terms of correction for HR and of the ability to identify infants with LQTS. The exception is represented by the Hodges correction formula which grossly overcorrected for the effect of HR and which had extremely poor positive predictive values for identification of LQTS infants. Among the four traditional formulae tested (Bazett, Fridericia, Hodges, and Framingham), the one proposed by Bazett 10 in 1920 turned out to be the best. Take home figure Individual QT/QTc values plotted vs. heart rate. The linear regression lines fitting the relationship between QT/QTc and heart rate are shown, along with the regression equation. The slope of QTcB was 0.086, which was the closest to zero.
QT interval correction in neonates . . . . . . . . . . . .
A vexed question
It is almost 100 years since Bazett described his formula to measure the QT interval. 10 Since then, several publications have strongly criticized the inability of his method to properly correct for HR changes leading to a search for better correction formulae.
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The excessive attention to the mathematical validity of the correction for HR might be understandable if the measurement of the actual QT interval were truly accurate, but this is seldom the case in clinical . . . . . . . . . . .
practice. We actually deal with a gross measurement and the end of the T-wave is often so indistinct that even expert cardiologists reach different conclusions. [22] [23] [24] Percentage of all neonates studied (n = 5000). formula used to distinguish between normal and abnormal values. In this regard, a group quite experienced with LQTS has recognized the consistent diagnostic value of the Bazett's correction, 25 a conclusion shared by others as well. 26 There is one specific condition in which there is indeed the need for extremely accurate measurements of the QT interval, and this concerns the studies with new drugs when regulatory agencies wish to exclude a possible QT prolongation of a magnitude that is likely to produce drug-induced LQTS even in apparently normal individuals. 27, 28 For this important objective, a careful and individualized QT correction formula such as the one proposed by Malik et al. 29 or a study population-specific correction formula is certainly appropriate. 30, 31 The priority here is to have a HR independent QT correction formula and this issue is quite different from the objective of identifying infants likely to be affected by LQTS. Similarly, accurate QT interval corrections are also needed in physiological studies that investigate other effects on myocardial repolarization.
Present data
In a set of ECGs recorded in 5000 healthy neonates between the 15th and the 25th day of life, we tested two commonly used linear formulae (Hodges' and Framingham) and two non-linear exponential formulae (Bazett's and Fridericia's). We also derived, and then tested, a population-specific non-linear exponential QT correction formula (QTcNeo), where the QTc value was obtained by QTcNeo = QT/ RR N , where the value of N was derived from 2500 randomly selected ECGs and was found to be 0.467. To decide which of these five formulae was the best or the most useful for assessing the QT interval in neonates, we used two criteria-the mathematical ability to provide a corrected QT value that was most HR independent, and the ability to correctly identify neonates with LQTS confirmed by genetic testing.
The first criterion was based on plotting the QTc by each of the five correction formulae vs. the HR values from all ECGs. The formula for which the linear regression line fitting the QTc-HR data was closest to horizontal would be considered the best, as this would imply that the corrected QT value was now independent of the HR. However, the difference between the slopes of QTcB and QTcNeo were clinically not significant, as the difference between them was only 0.9 ms for an increase in HR of 10 b.p.m. The inescapable conclusion is that QTcB provided the most HR independent QT correction in this cohort of 5000 neonates and would give acceptable results, given the ease of calculation and the fact that the Bazett's formula is familiar to most cardiologists worldwide.
The second criterion used was to compare the predictive value of each of these formulae to correctly identify neonates with the congenital LQTS. We found that the AuROC curve (a measure of the diagnostic accuracy of a test) was significantly less for the Hodges correction formula than the other four methods. The other four QT correction formulae had comparable areas under the ROC curve, suggesting that any one of them would be equally good in identifying neonates with the LQTS. The optimum cut-off values used to identify neonates with LQTS, however, varied widely. The cut-off values were 394 ms for QTcF, 460 ms for QTcB, 383 ms for QTcL, and 446 ms for QTcNeo. Each of these had a 100% negative predictive value but the positive predictive value was 39-40% for QTcB, QTcF, and QTcNeo and 32% for QTcL (Framingham formula). Considering the ease of calculation and the wide availability of QTcB, we concluded that QTcB best served the purpose of identifying neonates with the LQTS, although other correction formulae were also acceptable alternatives using the cut-off value that we found, except QTcH.
The present findings differ from what has been reported by a number of studies on QTc correction formulae in various populations. One possible explanation lies in the fact that most previous studies were performed in adults or older children who, for the most part, had HRs between 55 and 80 b.p.m. whereas newborns have HRs around 150 b.p.m.
Limitations
In the original study, initially only neonates with QTcB >470 ms and their families underwent genetic screening, but this was later extended to infants with a QTc between 460 and 470 ms. It is not possible to exclude that a few neonates with QTc >440 or 450 ms may have carried LQTS-causing mutations.
In our large prospective screening study, 1 one ECG was recorded in each neonate. Whenever a QTc >450 ms was found, the ECG was repeated within 2 weeks to confirm the initial finding, but only the first ECG was included in this study. Thus, the QTc vs. HR data analysed here contained only a single ECG from each neonate. If multiple ECGs are recorded in the same individual at different time points and various QTc methods are compared, the method that provides the best HR independent QTc value may differ from individual to individual. 29 However, a population-specific QT correction formula is the one necessary in clinical practice where usually only a single ECG is obtained per individual to screen for LQTS. Lastly, although more complex methods for modelling the QT-RR relationship have been proposed which might more accurately define the QT-RR relationship, 29 we limited our analysis to the development and validation of a single log-linear QT correction formula (QTcNeo) applicable over the entire range of HRs in neonates.
Our study also has some important strengths: the study included a large number of neonates prospectively studied for LQTS, the diagnosis of LQTS was confirmed by genetic testing, and all ECGs were high-resolution digital ECGs that were interpreted in a central laboratory.
Implications
The main implication of our study is that the Bazett's correction can be used with confidence when screening infants for the possible
